streptozocin
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
2 FDA-registered drug labelers
ESTEVE PHARMACEUTICALS, S.A.
Pfanstiehl, Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Zanosar
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Streptozocin Powder, For Solution
07/12/2022Available
current
Streptozocin Powder, For Solution
07/12/2022Unavailable
Chemical Identity
CAS18883-66-4
PubChem CID29327
DTXSIDDTXSID2021282
FormulaC8H15N3O7
Mol. Weight265.22 g/mol
SMILESCN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O
Data Sources
293272026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/streptozocin/cids/JSON
Archive: data/sources/pubchem_name/streptozocin.json
CAS 18883-66-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 18883-66-42026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json